Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of a Novel Ocular Lubricating Eye Drop
Sponsor: Pleryon Therapeutics (Hangzhou) Limited
Summary
The objective of this 2-part study is to assess the safety and tolerability of the new ocular lubricating drop ABR2 during short-term use in subjects for the temporary relief of ocular discomfort due to dryness of the eye. In Part 1, participant will receive 1 drop of ABR2 in one eye and through assessments over a 1-hour period. In Part 2, participant will use 1 drop of ABR2 at least two times a day for 28-day period (may use up to 4 times a day as needed) This is a single arm, open label study with no placebo or comparative arm.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-05
Completion Date
2027-05
Last Updated
2026-05-19
Healthy Volunteers
No
Conditions
Interventions
Part 2 ABR2 At least twice a day for 28 days
Use ABR2 at least BID, up to QID for 28 days
Part 1: ABR2 single dose in one eye
Receive a single dose in one eye only
Locations (1)
Centre for Ocular Research & Education, School of Optometry & Vision Science, University of Waterloo
Waterloo, Ontario, Canada